October 26, 2023
The Alliance for Clinical Trials in Oncology will convene the 2023 Alliance Fall Hybrid Group Meeting November 1-4. Newly elected Group Chair Dr. Evanthia Galanis will welcome distinguished oncology researchers, clinical trial specialists, and administrators from across the country to the four-day meeting that will take p
October 22, 2023
The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal trial evaluating cabozantinib compared with placebo in two cohorts of patients with previously treated neuroendocrine tumors: one cohort of patients with advanced pancreatic ne
October 5, 2023
The Alliance for Clinical Trials in Oncology today announced that the Alliance Data and Safety Monitoring Board (DSMB) determined that the phase III AMBASSADOR (A031501) trial met one of its dual primary endpoints of disease-free survival (DFS) for the adjuvant treatment of patients with localized muscle-invasive urothelial carcinoma (MIUC) and locally advanced urothelial carcinoma
